In summary, only GLP-1 (alone or in combination with GIP) stimulated insulin secretion (insulin, C-peptide and insulin secretion rates were calculated by deconvolution) and lowered plasma glucose in previously hyperglycaemic individuals with type 2 diabetes; GIP alone had no significant effects. Here, GLP1R is linked to type 2 diabetes mellitus.